Cleared Traditional

K923099 - X-RAY DRAPES (FDA 510(k) Clearance)

Class I Radiology device.

K923099 · Hydro-Med Products, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1992
Decision
112d
Days
Class 1
Risk

K923099 is an FDA 510(k) clearance for the X-RAY DRAPES. Classified as Curtain, Protective, Radiographic (product code IWQ), Class I - General Controls.

Submitted by Hydro-Med Products, Inc. (Dallas, US). The FDA issued a Cleared decision on October 15, 1992 after a review of 112 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.6500 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Hydro-Med Products, Inc. devices

Submission Details

510(k) Number K923099 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 25, 1992
Decision Date October 15, 1992
Days to Decision 112 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
5d slower than avg
Panel avg: 107d · This submission: 112d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code IWQ Curtain, Protective, Radiographic
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 892.6500
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.